The demarcation between drugs and medical devices

Latest Perspectives

• April 28

  2021

  Déjà Vu All Over Again: Life Sciences Companies Brace for More US and Global Tax Reform

• April 14

  2021

  Patent Considerations for Optimizing Immunotherapies with the Help of Artificial Intelligence

  Immuno-Innovation Blog
• 

  March 09

  2021

  Slow Steam Ahead: The Hong Kong Government’s Policy for Digital Healthcare in 2021